BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37481941)

  • 1. Unveiling the protein signature of the human osteosarcoma 3AB-OS cancer stem cell line.
    Imperlini E; Corbo C
    Biochem Biophys Res Commun; 2023 Oct; 676():36-41. PubMed ID: 37481941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutant p53 gain of function can be at the root of dedifferentiation of human osteosarcoma MG63 cells into 3AB-OS cancer stem cells.
    Di Fiore R; Marcatti M; Drago-Ferrante R; D'Anneo A; Giuliano M; Carlisi D; De Blasio A; Querques F; Pastore L; Tesoriere G; Vento R
    Bone; 2014 Mar; 60():198-212. PubMed ID: 24373920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness.
    Di Fiore R; Fanale D; Drago-Ferrante R; Chiaradonna F; Giuliano M; De Blasio A; Amodeo V; Corsini LR; Bazan V; Tesoriere G; Vento R; Russo A
    J Cell Physiol; 2013 Jun; 228(6):1189-201. PubMed ID: 23129384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-29b-1 impairs in vitro cell proliferation, self‑renewal and chemoresistance of human osteosarcoma 3AB-OS cancer stem cells.
    Di Fiore R; Drago-Ferrante R; Pentimalli F; Di Marzo D; Forte IM; D'Anneo A; Carlisi D; De Blasio A; Giuliano M; Tesoriere G; Giordano A; Vento R
    Int J Oncol; 2014 Nov; 45(5):2013-23. PubMed ID: 25174983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling human osteosarcoma in mice through 3AB-OS cancer stem cell xenografts.
    Di Fiore R; Guercio A; Puleio R; Di Marco P; Drago-Ferrante R; D'Anneo A; De Blasio A; Carlisi D; Di Bella S; Pentimalli F; Forte IM; Giordano A; Tesoriere G; Vento R
    J Cell Biochem; 2012 Nov; 113(11):3380-92. PubMed ID: 22688921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells.
    Di Fiore R; Drago-Ferrante R; Pentimalli F; Di Marzo D; Forte IM; Carlisi D; De Blasio A; Tesoriere G; Giordano A; Vento R
    J Cell Physiol; 2016 Aug; 231(8):1832-41. PubMed ID: 26679758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Energy metabolism characterization of a novel cancer stem cell-like line 3AB-OS.
    Palorini R; Votta G; Balestrieri C; Monestiroli A; Olivieri S; Vento R; Chiaradonna F
    J Cell Biochem; 2014 Feb; 115(2):368-79. PubMed ID: 24030970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and expansion of human osteosarcoma-cancer-stem cells by long-term 3-aminobenzamide treatment.
    Di Fiore R; Santulli A; Ferrante RD; Giuliano M; De Blasio A; Messina C; Pirozzi G; Tirino V; Tesoriere G; Vento R
    J Cell Physiol; 2009 May; 219(2):301-13. PubMed ID: 19160414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin inhibits the proliferation, metastasis, and cancer stem-like sphere formation in osteosarcoma MG63 cells in vitro.
    Chen X; Hu C; Zhang W; Shen Y; Wang J; Hu F; Yu P
    Tumour Biol; 2015 Dec; 36(12):9873-83. PubMed ID: 26164004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective autophagy leads to the suppression of stem-like features of CD271
    Zhang D; Zhao Q; Sun H; Yin L; Wu J; Xu J; He T; Yang C; Liang C
    J Biomed Sci; 2016 Nov; 23(1):82. PubMed ID: 27863492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface proteomic analysis of differentiated versus stem-like osteosarcoma human cells.
    Gemei M; Corbo C; D'Alessio F; Di Noto R; Vento R; Del Vecchio L
    Proteomics; 2013 Nov; 13(22):3293-7. PubMed ID: 24106197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-walled carbon nanotube: One specific inhibitor of cancer stem cells in osteosarcoma upon downregulation of the TGFβ1 signaling.
    Miao Y; Zhang H; Pan Y; Ren J; Ye M; Xia F; Huang R; Lin Z; Jiang S; Zhang Y; Songyang Z; Zhang Y
    Biomaterials; 2017 Dec; 149():29-40. PubMed ID: 28988062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bufalin Inhibits the Differentiation and Proliferation of Cancer Stem Cells Derived from Primary Osteosarcoma Cells through Mir-148a.
    Chang Y; Zhao Y; Gu W; Cao Y; Wang S; Pang J; Shi Y
    Cell Physiol Biochem; 2015; 36(3):1186-96. PubMed ID: 26111756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics of osteosarcoma.
    Bernardini G; Laschi M; Geminiani M; Santucci A
    Expert Rev Proteomics; 2014 Jun; 11(3):331-43. PubMed ID: 24654989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
    Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
    BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-associated mesenchymal stroma fosters the stemness of osteosarcoma cells in response to intratumoral acidosis via NF-κB activation.
    Avnet S; Di Pompo G; Chano T; Errani C; Ibrahim-Hashim A; Gillies RJ; Donati DM; Baldini N
    Int J Cancer; 2017 Mar; 140(6):1331-1345. PubMed ID: 27888521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAFB Promotes Cancer Stemness and Tumorigenesis in Osteosarcoma through a Sox9-Mediated Positive Feedback Loop.
    Chen Y; Wang T; Huang M; Liu Q; Hu C; Wang B; Han D; Chen C; Zhang J; Li Z; Liu C; Lei W; Chang Y; Wu M; Xiang D; Chen Y; Wang R; Huang W; Lei Z; Chu X
    Cancer Res; 2020 Jun; 80(12):2472-2483. PubMed ID: 32234710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA HIF2PUT inhibited osteosarcoma stem cells proliferation, migration and invasion by regulating HIF2 expression.
    Zhao D; Wang S; Chu X; Han D
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1342-1348. PubMed ID: 30966832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HDAC2 depletion promotes osteosarcoma's stemness both in vitro and in vivo: a study on a putative new target for CSCs directed therapy.
    La Noce M; Paino F; Mele L; Papaccio G; Regad T; Lombardi A; Papaccio F; Desiderio V; Tirino V
    J Exp Clin Cancer Res; 2018 Dec; 37(1):296. PubMed ID: 30509303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic implications of an enriched cancer stem-like cell population in a human osteosarcoma cell line.
    Martins-Neves SR; Lopes ÁO; do Carmo A; Paiva AA; Simões PC; Abrunhosa AJ; Gomes CM
    BMC Cancer; 2012 Apr; 12():139. PubMed ID: 22475227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.